PTLA

Portola Pharmaceuticals, Inc.
PTLA

Overview Fund Activity
Delisted

PTLA was delisted on the 1st of July, 2020.

Back to rankings

215 hedge funds and large institutions have $2.82B invested in Portola Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 93 increasing their positions, 55 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
215
Holders Change
-6
Holders Change %
-2.71%
% of All Funds
4.88%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
31
Increased
93
Reduced
55
Closed
37
Calls
$18.7M
Puts
$41.4M
Net Calls
-$22.7M
Net Calls Change
-$8.93M

Top Buyers

1
PHS
PFM Health Sciences
California
$289M
2
Wells Fargo
Wells Fargo
California
$33.4M
3
Wellington Management Group
Wellington Management Group
Massachusetts
$292M
4
CCM
Cadian Capital Management
New York
$74.2M
5
BlackRock
BlackRock
New York
$229M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$207M
2
Citadel Advisors
Citadel Advisors
Florida
$1.28M
3
CAM
Cormorant Asset Management
Massachusetts
$0
4
LCM
Laurion Capital Management
New York
$0
5
Millennium Management
Millennium Management
New York
$501K
Name Holding Trade Value Shares
Change 		Shares
Change %
AFNAS
251
American Financial Network Advisory Services
California
– -$3K -50 Closed
MIM
252
Monashee Investment Management
Massachusetts
– -$5.84M – –
7 8 9 10
11